GA²LEN, the Global Allergy and Asthma European Network, is a consortium of leading European research centres specialized in allergic diseases, which include asthma. Funded by the European Union under the 6th framework programme, GA²LEN addresses the growing public health concern of allergic diseases.

Research teams were chosen for their scientific excellence, their record on multidisciplinary working and international collaboration, and their educational activities. Since the launch of the Network, it has grown to include an additional 50 collaborating centres making GA²LEN one of the largest multidisciplinary networks of researchers in allergy and asthma worldwide.

Integrating European research

Europe has produced some of the most important recent findings on allergy and asthma, but research tends to be fragmented in different institutes and even in different departments of the same organization. Findings are not always shared nor rapidly translated into changes in practice. The GA²LEN Network of Excellence (NoE) exists to help integrate research activities in Europe and to establish the structure for a European Research Area of excellence in allergy and asthma that will endure.

Spreading knowledge and excellence

The network aims to accelerate the application of research results into clinical practice, to meet the needs of patients, and to help guide policy development. It also aims to promote training and greater integration between public and private sectors in this medical field.